Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Comparative Study of Risperidone Versus Olanzapine Versus Quetiapine for Mania in Children and Adolescents With Bipolar I and Bipolar II Disorder

NCT00182013 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT00182013
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00182013 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Comparative Study of Risperidone Versus Olanzapine Versus Quetiapine for Mania in Children and Adolescents With Bipolar I and Bipolar II Disorder
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2001
Completion date
Not reported
Enrollment
106 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar spectrum disorder